Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Weak
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.2.9247.4144
Address
Level 8, Suite 2 66 Clarence Street Sydney, New South Wales (NSW) 2000
Description
Uscom Ltd. engages in the development, design, manufacture, and marketing of non-invasive cardiovascular and pulmonary medical devices. It operates through the following geographical segments: Australia, Asia, Americas, and Europe. The company was founded by Robert Allan Phillips on December 23, 1999 and is headquartered in Sydney, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.05
Trade Value (12mth)
AU$201.00
1 week
0%
1 month
-6.25%
YTD
0%
1 year
-26.83%
All time high
3.86
EPS 3 yr Growth
90.30%
EBITDA Margin
-53.40%
Operating Cashflow
-$1m
Free Cash Flow Return
-30.50%
ROIC
-54.40%
Interest Coverage
-15.10
Quick Ratio
2.50
Shares on Issue (Fully Dilluted)
245m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
29 October 24 |
Change of Director's Interest Notice - Phillips
×
Change of Director's Interest Notice - Phillips |
25 October 24 |
FY24 AGM Presentation and Update
×
FY24 AGM Presentation and Update |
25 October 24 |
Results of 2024 AGM
×
Results of 2024 AGM |
25 October 24 |
Notification regarding unquoted securities - UCM
×
Notification regarding unquoted securities - UCM |
30 September 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
24 September 24 |
Letter to shareholders re AGM
×
Letter to shareholders re AGM |
24 September 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
04 September 24 |
Application for quotation of securities - UCM
×
Application for quotation of securities - UCM |
04 September 24 |
Cleansing notice
×
Cleansing notice |
29 August 24 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 August 24 |
Appendix 4G
×
Appendix 4G |
29 August 24 |
Corporate Governance Statement
×
Corporate Governance Statement |
31 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
05 July 24 |
Change of Director's Interest Notice - Phillips
×
Change of Director's Interest Notice - Phillips |
03 July 24 |
Application for quotation of securities - UCM
×
Application for quotation of securities - UCM |
03 July 24 |
Cleansing notice
×
Cleansing notice |
21 June 24 |
Ceasing to be a substantial holder - Jetan
×
Ceasing to be a substantial holder - Jetan |
21 June 24 |
Becoming a substantial holder - Neja
×
Becoming a substantial holder - Neja |
24 April 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
05 March 24 |
Application for quotation of securities - UCM
×
Application for quotation of securities - UCM |
05 March 24 |
Change of Director's Interest Notice - Phillips
×
Change of Director's Interest Notice - Phillips |
05 March 24 |
Change in substantial holding - Phillips
×
Change in substantial holding - Phillips |
04 March 24 |
Application for quotation of securities - UCM
×
Application for quotation of securities - UCM |
04 March 24 |
Change of Director's Interest Notice - Phillips
×
Change of Director's Interest Notice - Phillips |
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.